These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 16533710)

  • 1. Optimizing the use of open-source software applications in drug discovery.
    Geldenhuys WJ; Gaasch KE; Watson M; Allen DD; Van der Schyf CJ
    Drug Discov Today; 2006 Feb; 11(3-4):127-32. PubMed ID: 16533710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular conceptor for training in medicinal chemistry, drug design, and cheminformatics.
    Cohen C; Fischel O; Cohen E
    Chem Biol Drug Des; 2007 Jan; 69(1):75-82. PubMed ID: 17313460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WinDock: structure-based drug discovery on Windows-based PCs.
    Hu Z; Southerland W
    J Comput Chem; 2007 Nov; 28(14):2347-51. PubMed ID: 17476686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug Guru: a computer software program for drug design using medicinal chemistry rules.
    Stewart KD; Shiroda M; James CA
    Bioorg Med Chem; 2006 Oct; 14(20):7011-22. PubMed ID: 16870456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in computer-aided drug design.
    Song CM; Lim SJ; Tong JC
    Brief Bioinform; 2009 Sep; 10(5):579-91. PubMed ID: 19433475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QSAR modeling and computer-aided design of antimicrobial peptides.
    Jenssen H; Fjell CD; Cherkasov A; Hancock RE
    J Pept Sci; 2008 Jan; 14(1):110-4. PubMed ID: 17847019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating structure-based and ligand-based approaches for computational drug design.
    Wilson GL; Lill MA
    Future Med Chem; 2011 Apr; 3(6):735-50. PubMed ID: 21554079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced in silico approaches in antiviral research.
    Zonta N; Coluccia A; Brancale A
    Antivir Chem Chemother; 2010 Mar; 20(4):147-51. PubMed ID: 20231779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating molecular design resources within modern drug discovery research: the Roche experience.
    Stahl M; Guba W; Kansy M
    Drug Discov Today; 2006 Apr; 11(7-8):326-33. PubMed ID: 16580974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An introduction to the computer-aided structure-based drug design--applications of bioinformatics to drug discovery].
    Hirono S
    Rinsho Byori; 2002 Jan; 50(1):45-51. PubMed ID: 11871136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competitive Workflow: novel software architecture for automating drug design.
    Cartmell J; Krstajic D; Leahy DE
    Curr Opin Drug Discov Devel; 2007 May; 10(3):347-52. PubMed ID: 17554862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based drug design to augment hit discovery.
    Kalyaanamoorthy S; Chen YP
    Drug Discov Today; 2011 Sep; 16(17-18):831-9. PubMed ID: 21810482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational classification of classically secreted proteins.
    Klee EW; Sosa CP
    Drug Discov Today; 2007 Mar; 12(5-6):234-40. PubMed ID: 17331888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated in silico tools for exploiting the natural products' bioactivity.
    Rollinger JM; Langer T; Stuppner H
    Planta Med; 2006 Jun; 72(8):671-8. PubMed ID: 16783689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of KiBank, a database supporting structure-based drug design.
    Zhang J; Aizawa M; Amari S; Iwasawa Y; Nakano T; Nakata K
    Comput Biol Chem; 2004 Dec; 28(5-6):401-7. PubMed ID: 15556481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Search for new antagonist ligands for adenosine receptors from QSAR point of view. How close are we?
    González MP; Terán C; Teijeira M
    Med Res Rev; 2008 May; 28(3):329-71. PubMed ID: 17668454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative structure-activity relationship: promising advances in drug discovery platforms.
    Wang T; Wu MB; Lin JP; Yang LR
    Expert Opin Drug Discov; 2015 Dec; 10(12):1283-300. PubMed ID: 26358617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TOPS-MODE based QSARs derived from heterogeneous series of compounds. Applications to the design of new anti-inflammatory compounds.
    Pérez González M; Dias LC; Helguera AM; Rodríguez YM; de Oliveira LG; Gomez LT; Diaz HG
    Bioorg Med Chem; 2004 Aug; 12(16):4467-75. PubMed ID: 15265497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Open source software and web services for designing therapeutic molecules.
    Singla D; Dhanda SK; Chauhan JS; Bhardwaj A; Brahmachari SK; ; Raghava GP
    Curr Top Med Chem; 2013; 13(10):1172-91. PubMed ID: 23647540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.